Showing results (151-160 of 352) with videos related to
Sort By:
Pageof 36
Expert Review of Anticancer Therapy|November 27, 2012
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathwaysAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.Expert Review of Molecular Diagnostics|December 22, 2012
Towards a clinical use of miRNAs in pancreatic cancer biopsiesAdam E Frampton, Tamara M H Gall, Leandro Castellano, et al.Cancer|February 21, 2008
Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatmentsJustin Stebbing, Christopher Wood, Michael Atkins, et al.Cancer Epidemiology|February 8, 2017
The relationship between ethnicity, social deprivation and late presentation of colorectal cancerAlan Askari, Subramanian Nachiappan, Andrew Currie, et al.Expert Review of Molecular Diagnostics|February 7, 2015
Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreasAdam E Frampton, Justin Stebbing, Tamara M H Gall, et al.Frontiers in Immunology|October 22, 2021
A Pan-Cancer Analysis of SMARCA4 Alterations in Human CancersLing Peng, Jisheng Li, Jie Wu, et al.Ecancermedicalscience|February 28, 2024
Disparities in the consensus for treatment of chemotherapy-induced thrombocytopeniaLiana Hambardzumyan, Henrik Grigoryan, Maria Badikyan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphomaJustin Stebbing, Brian Gazzard, Sundhiya Mandalia, et al.Expert Review of Molecular Diagnostics|March 13, 2013
Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancerTamara M H Gall, Adam E Frampton, Jonathan Krell, et al.Frontiers in Oncology|June 6, 2022
A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the LiteratureQi Zhu, Mingyun Jiang, Wenfei Li, et al.Pageof 36